These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lyme disease. Cunha BA Compr Ther; 1993; 19(4):135. PubMed ID: 8261766 [No Abstract] [Full Text] [Related]
5. Guillain-Barré syndrome in a child with serologic evidence of Borrelia burgdorferi infection. Shapiro EE Pediatr Infect Dis J; 1998 Mar; 17(3):264-5. PubMed ID: 9535265 [No Abstract] [Full Text] [Related]
6. [Suspected Lyme borreliosis: how to diagnose, whom to treat?]. Bernasconi E; Nadal D; Vogt M Ther Umsch; 1992 Apr; 49(4):257-62. PubMed ID: 1615461 [TBL] [Abstract][Full Text] [Related]
7. Empiric antibiotic treatment of patients who are seropositive for Lyme disease but lack classic features. American College of Rheumatology and the Infectious Diseases Society of America. Luft BJ; Gardner P; Lightfoot RW Clin Infect Dis; 1994 Jan; 18(1):112. PubMed ID: 8054419 [No Abstract] [Full Text] [Related]
8. [Neurological manifestations of Borrelia burgdorferi infection (Lyme disease)]. Pepin JL; Bastings E; Lenaerts M; Maertens de Noordhout A; Schoenen J; Delwaide PJ Rev Med Liege; 1994 Nov; 49(11):603-10. PubMed ID: 7800998 [No Abstract] [Full Text] [Related]
10. Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. Hilton E; Tramontano A; DeVoti J; Sood SK J Clin Microbiol; 1997 Mar; 35(3):774-6. PubMed ID: 9041433 [TBL] [Abstract][Full Text] [Related]
11. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082 [TBL] [Abstract][Full Text] [Related]
12. [Outbreak of Lyme borreliosis with joint manifestation--case report]. Biesiada G; Czepiel J; Skwara P; Sobczyk-Krupiarz I; Mach T Przegl Lek; 2006; 63(4):231-3. PubMed ID: 17080747 [TBL] [Abstract][Full Text] [Related]
13. Lyme disease. A general survey. Trevisan G; Cinco M Int J Dermatol; 1990; 29(1):1-8. PubMed ID: 2133980 [No Abstract] [Full Text] [Related]
17. Lyme borreliosis: perspective of a scientist-patient. Hamlen R Lancet Infect Dis; 2004 Oct; 4(10):603-4. PubMed ID: 15451481 [No Abstract] [Full Text] [Related]
18. [Lyme borreliosis. The manifestations of the disease from the internal medicine and rheumatology viewpoints]. Röther E; Peter HH Fortschr Med; 1990 Apr; 108(10):187-90. PubMed ID: 2187777 [TBL] [Abstract][Full Text] [Related]
19. Lyme antibodies and Lyme disease: when to measure and who to treat. Lightfoot RW Bull Rheum Dis; 1991; 40(5):1-3. PubMed ID: 1797295 [No Abstract] [Full Text] [Related]
20. Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. Kaiser R J Neurol; 1994 Dec; 242(1):26-36. PubMed ID: 7897449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]